Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1141)	12/16/1999 11:41:00 AM
From: RCMac	Respond to of 4974

>> NBIX..... not a bullet-proof business plan, but armor could pop up from any one of several projects. And, Jay Silverman at BBRS used the "ever" word. << The "ever" word, for those who missed it or are finding Rick even more gnomic than usual, was used as follows: ''Despite a recent run-up, Neurocrine, in our opinion, is only beginning to reflect the potential of these novel compounds,'' said Silverman. ''While the insomnia drug may compete effectively, the potential of the CRF program is as large as any blockbuster drug ever, in our opinion.'' Message 12055798 --RCM